eHealth Entrepreneurship
79,00 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 1-2 Wochen
payback
0 °P sammeln
  • Gebundenes Buch

Digital health technologies are rapidly changing the practice of medicine and the doctor-patient relationship. While the digital health market is booming, a high percentage of eHealth start-ups are not successful in the mid or long term. We decided to publish this book in order to help emerging business ideas in the field of eHealth understand and develop the keys to success.

Andere Kunden interessierten sich auch für
Produktbeschreibung
Digital health technologies are rapidly changing the practice of medicine and the doctor-patient relationship. While the digital health market is booming, a high percentage of eHealth start-ups are not successful in the mid or long term. We decided to publish this book in order to help emerging business ideas in the field of eHealth understand and develop the keys to success.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Heidrun Flaadt Cervini: Dr. Heidrun Flaadt Cervini studied Biology at the University of Constance where she also completed her PhD. After her postdoctoral studies at Ecole Normale Supérieure in Paris, she attended Management Education in Zurich. She then served as COO of Diagene, a spin-off company at University of Basel. During that time, the company completed the first capital round. Driven by her interest for technology transfer she took over a position at the Office of Technology Transfer (OTT) at the University of Basel. In 2005, she started to build up a new OTT at EMPA in Dübendorf that she headed until end of 2007. In 2008, she moved to Ticino to join her husband and received a mandate from the Università della Svizzera italiana in Lugano to create new Executive Programs in the field of bio- and medtech entrepreneurship. Among others, she developed and implemented the BioBusiness, MedTech Business and eHealth Business program. Heidrun Flaadt Cervini is now the director of CASE BioMed, Center of Advanced Studies on Entrepreneurship in Biomedicine at USI. Heidrun Flaadt is also one of 16 Women in Healthcare Innovation 2021. The award was presented to her by the Innovation Office of the University of Basel (in collaboration with Impact Hub Basel, Healthcare Businesswomen Association, WomenMatters and WEHub) for her work as director of the Center of Advanced Studies on Entrepreneurship in BioMedicine (CASE BioMed) at the Faculty of Biomedical Sciences, Università della Svizzera italiana and her significant contribution to innovation. She has been on the advisory board of Swiss Healthcare Startups since 2024. Jörg Dogwiler: After graduating as Master of Engineering in electronics from ETH Zurich, Jörg Dogwiler joined ABB Power Systems as a system engineer in 1994 and later became group leader in systems engineering for combined cycle power plants. In 2000, he moved to Zühlke Engineering where he was project manager responsible for the development of various industrial products, including those for medical devices. During this period, he successfully filed for several patents to protect inventions in the field of infusion pumps. In 2006, he joined Confinis AG as partner, and spent 10 years playing an active role in the successful development of the medical device consultancy company. During this period, he acted as senior consultant and senior project manager on various customer projects specialized in the field of medical devices working, amongst others, on the implementation of quality management systems, global product registrations and operative quality support. Since 2016, as founder and CEO of Congenius AG, he is in charge of the consultancy company that specializes in the field of medical devices, pharmaceuticals, diagnostics and biotechnology in Switzerland and abroad. In total, Jörg combines more than 20 years of experience in development and regulatory affairs of medical devices. He has supported several start-up companies, from a regulatory point of view, that are successfully marketing their medical devices.